… by prime-boost vaccines in humans. In the present report, we have combined data from several
prime-boost vaccine trials using different … the heterologous prime-boost vaccine regimens …

… immunogenicity and efficacy compared to the same vaccine … the strategy of heterologous
prime–boost regimes as a robust … Previously, DNA vaccines were approved only for veterinary …

… comparative immunogenicity trial of six different vaccine vectors … Plasmid DNA was purified
using standard methods and was … resulting from heterologous prime-boost regimens in which …

… were calculated using Kruskal-Wallis test with Dunn’s multiple … whether the different vaccine
regimens were associated with … numbers were calculated based on differential blood counts. …

… We have described several DNA-vectored vaccines conferring … from vector immunogenicity,
and the advantage of viral-vectored … In summary, the heterologous prime-boost regimen …

… Several efforts have been employed to improve the efficacy … malayi L3 in the peritoneal
cavity and therefore differential … in FIA, in heterologous prime boost regimen mice were primed …

… Therefore, improving the immunogenicity of DNA vaccines in … DNA/protein, DNA/viral/protein
prime–boost regimes have … Owing to the unforeseen failures of many recent vaccine trials…

… the safety and immunogenicity of the DNA/MVA regimen in developing countries, is … of
heterologous prime–boost regimens comprising adenoviral vaccine vectors that belong to different …

… the potential of multiple heterologous viral booster vaccines, … Unlike DNA-based and
protein-based vaccines, viral vectors with … antibody subclasses reflects the differential nature of the …

… and show that a heterologous prime/boost strategy with a … Finally, while all prophylactic
prime/boost vaccine regimens … vectors, DNA or RNA vaccines, or adjuvanted subunit vaccines. …